Inicio > SANCHEZ ANTOLIN, MARIA GLORIA

SANCHEZ ANTOLIN, MARIA GLORIA

PROFESOR ASOCIADO CIENCIAS DE LA SALUD
 

Índice H en Scopus: 15
 

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80385]], camposKey:0930-2794 2023-09-01 Antimigration versus conventional fully covered metal stents in the endoscopic treatment of anastomotic biliary strictures after deceased-donor liver transplantation69756982, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78888]], camposKey:2340-4167 2023-01-01 Diagnóstico oportunista basado en la edad y eliminación de la hepatitis C: un paso imprescindible para mejorar la salud hepática global128132, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78887]], camposKey:0210-5705 2023-01-01 Patient journey of individuals tested for HCV in Spain: LiverTAI, a retrospective analysis of EHRs through natural language processing491503, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68478]], camposKey:1130-0108 2022-06-01 Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study335342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78886]], camposKey:2340-4167 2022-01-01 Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study335342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68479]], camposKey:0973-6883 2022-01-01 Postreperfusion Liver Biopsy as Predictor of Early Graft Dysfunction and Survival After Orthotopic Liver Transplantation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70589]], camposKey:1134-2072 2022-01-01 Seguimiento del trasplantado hepático en Atención Primaria261267, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66185]], camposKey:0210-5705 2021-11-01 Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt Resultados clínicos a largo plazo y predictores de la supervivencia de pacientes con cirrosis hepática tras inserción de prótesis recubierta transyugular intrahepática porto-sistémica dilatadas a 10 mm620627, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66186]], camposKey:1138-3593 2021-07-01 Internal validity of a rapid test for COVID-19 antigens in a nursing home Validez interna de una prueba rápida de detección de antígenos COVID-19 en una residencia de mayores332336, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66188]], camposKey:0954-691X 2021-01-01 De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: Prevalence and predictive factors399406, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66189]], camposKey:0041-1337 2021-01-01 Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation602607, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70618]], camposKey:0210-5705 2021-01-01 Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt620627, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66187]], camposKey:0213-005X 2021-01-01 Population-based screening for acute SARS-CoV-2 infection using rapid antigen testing and the 5% pre-test probability. Is the specificity our problem? Cribados en la infección por SARS-CoV-2 empleando pruebas rápidas de antígenos en poblaciones con baja prevalencia (<5%). ¿Es la especificidad nuestro problema?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64728]], camposKey:1138-3593 2021-01-01 Validez interna de una prueba rápida de detección de antígenos COVID-19 en una residencia de mayores332336, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66192]], camposKey:0041-1345 2020-06-01 Hemophagocytic Syndrome as Uncommon Cause of Severe Pancytopenia After Liver Transplantation15001502, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66191]], camposKey:0041-1345 2020-06-01 Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective Analysis15071510, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66190]], camposKey:0041-1345 2020-06-01 Utility of Ethyl-Glucuronide for Evaluation of Abstinence in Patients Presenting for Liver Transplantation14501452, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66193]], camposKey:0166-3542 2020-02-01 Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68480]], camposKey:1130-0108 2019-11-01 Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)862873, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68481]], camposKey:0210-5705 2019-11-01 Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH) Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH)579592, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68482]], camposKey:0210-5705 2019-03-01 A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain Estudio observacional, retrospectivo y prospectivo a 12 meses del coste socioeconómico del síndrome del intestino irritable moderado a grave con estreñimiento en España141149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68483]], camposKey:0041-1345 2019-01-01 Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C7476, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63198]], camposKey:0041-1345 2019-01-01 Utility of Oral Anticoagulants as Prophylaxis of Recurrent Portal Thrombosis after Liver Transplantation8386, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68484]], camposKey:1600-6135 2018-10-01 Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study25132522, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68485]], camposKey:1130-0108 2018-01-01 Prevalence and progression of chronic kidney disease after liver transplant: A prospective, real-life, observational, two-year multicenter study538543, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68487]], camposKey:0168-8278 2017-12-01 Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation11681176, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68486]], camposKey:1478-3223 2017-12-01 High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 418231832, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68488]], camposKey:1007-9327 2017-11-07 Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study74597469, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68489]], camposKey:0934-0874 2017-10-01 Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study10411050, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68490]], camposKey:1542-3565 2017-06-01 Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68491]], camposKey:0041-1345 2016-11-01 Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort30133016, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68492]], camposKey:0041-1345 2016-11-01 Metabolic Syndrome After Liver Transplantation: Five-Year Prevalence and Risk Factors30103012, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68493]], camposKey:0954-691X 2016-03-04 Review of imaging techniques in the diagnosis of hepatocellular carcinoma in patients who require a liver transplant412420, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68494]], camposKey:0270-9139 2016-02-01 Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma488498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68495]], camposKey:0041-1337 2016-01-01 Impact of cytomegalovirus infection on severe hepatitis c recurrence in patients undergoing liver transplantation593599, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68496]], camposKey:0009-739X 2015-12-01 V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante619637, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68497]], camposKey:0210-5705 2015-08-01 A patient with dyspepsia and a giant abdominal tumor Paciente con dispepsia y tumoración abdominal gigante439441, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68498]], camposKey:0902-0063 2015-08-01 Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients667677, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68499]], camposKey:1478-3223 2015-02-01 Barriers to HCV treatment in the era of triple therapy: A prospective multi-centred study in clinical practice401408, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68500]], camposKey:1665-2681 2015-01-01 High efficacy and safety of triple therapy in hcv genotype 1 and moderate fibrosis: A multicenter study of clinical practice in Spain477486, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68501]], camposKey:0041-1345 2015-01-01 Severe anemia, gastric ulcer, pneumonitis and cholangitis in a liver transplant patient: Multiple organic dysfunction and one etiology: A case report136138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68502]], camposKey:1600-6135 2014-03-01 "very early" intrahepatic cholangiocarcinoma in cirrhotic patients: Should liver transplantation be reconsidered in these patients?660667, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68504]], camposKey:0003-4932 2014-01-01 Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: A spanish matched cohort multicenter study944952, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68503]], camposKey:0016-5107 2014-01-01 Magnetic compression anastomosis through EUS-guided choledochoduodenostomy to repair a disconnected bile duct in orthotopic liver transplantation520521, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68506]], camposKey:0041-1345 2012-07-01 Cutaneous mucormycosis infection by Absidia in two consecutive liver transplant patients15621564, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68505]], camposKey:0041-1345 2012-07-01 Early and extended therapy for recurrent hepatitis C after liver transplantation15711573, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39133]], camposKey:0213-005X 2011-01-01 Gene expression profiling in the first twelve weeks of treatment in chronic hepatitis C patients Perfiles de expresión génica en las primeras doce semanas de tratamiento en pacientes con hepatitis C crónica573580, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68507]], camposKey:0041-1345 2010-10-01 Covered metal stents for the treatment of biliary complications after orthotopic liver transplantation29662969, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39137]], camposKey:1148-5493 2010-01-01 Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin8491, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60702]], camposKey:0041-1345 2010-01-01 Risk of Development of the Metabolic Syndrome After Orthotopic Liver Transplantation663665, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68510]], camposKey:0041-1345 2009-04-01 FibroScan Evaluation of Liver Fibrosis in Liver Transplantation10441046, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68508]], camposKey:0210-5705 2009-04-01 Micobacterium kansasii infection after liver trasplantation Infección por Mycobacterium kansasii tras el trasplante hepático283286, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68509]], camposKey:0041-1345 2009-04-01 Milan Criteria Versus San Francisco Criteria in Hepatocellular Carcinoma: Our Center's Experience10121013, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60703]], camposKey:1007-9327 2008-01-01 Acalculous cholecystitis due to Salmonella enteritidis64086409, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=14021]], camposKey:0210-5705 2006-01-01 Fístula arterioportal sintomática resuelta mediante tratamiento conservador2370, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38205]], camposKey:1130-0108 2006-01-01 Impact of dietary intake and nutritional status on outcomes after liver transplantation Efecto de la ingesta y del estado nutricional en el trasplante hepático613, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68511]], camposKey:0210-5705 2006-01-01 Symptomatic hepatic arterioportal shaunt resolved through conservative treatment Fístula arterioportal sintomática resuelta mediante tratamiento conservador237239, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68512]], camposKey:1130-0108 2005-05-01 Budd-Chiari syndrome and heterozygotic mutation of metylenetetrahidrofolate reductase [2] Síndrome de Budd-Chiari y mutación heterozigótica de la metilenetetrahidrofolato-reductasa (MTHFR)379380, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68513]], camposKey:0210-5705 2003-11-01 Clear cell hepatocarcinoma [3] Hepatocarcinoma de células claras615617, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68514]], camposKey:0926-9959 2003-11-01 Red fingers syndrome and recurrent panniculitis in a patient with chronic hepatitis C692694, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44710]], camposKey:0304-5412 2000-01-01 ALTERACIONES DE LA FUNCIÓN MOTORA ESOFÁGICA713, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44712]], camposKey:0304-5412 2000-01-01 Indicaciones de las pruebas funcionales pancreáticas419421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44709]], camposKey:0304-5412 2000-01-01 PATOLOGÍA ESOFÁGICA POR REFLUJO: MECANISMOS ETIOPATOGENICOS, MANIFESTACIONES CLÍNICAS, COMPLICACIONES Y CRITERIOS DIAGNOSTICOS2330, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43348]], camposKey:0304-5412 2000-01-01 PROTOCOLO DE INDICACIONES DE DERIVACIÓN DE PATOLOGÍA ESOFAGICA DE MEDICINA PRIMARIA A ESPECIALIZADA4850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44711]], camposKey:0304-5412 2000-01-01 Protocolo diagnóstico del paciente con elevación de amilasas425427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44708]], camposKey:0210-5705 1999-01-01 Prospective study of gastroesophageal reflux after esophageal variceal band ligation386390, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68515]], camposKey:0210-5705 1999-01-01 Prospective study of gastroesophageal reflux after esophageal variceal band ligation Estudio prospectivo del reflujo gastroesofágico tras ligadura de varices esofágicas con bandas elásticas.386390, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68516]], camposKey:1130-0108 1997-12-01 Relación entre la forma de inicio y la edad del diagnóstico en la pancreatitis crónica alcohólica y no alcohólica. Análisis de 164 pacientes269273, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68517]], camposKey:1130-0108 1997-12-01 Relationship between the presenting symptoms and age at diagnosis in alcoholic and nonalcoholic chronic pancreatitis: Analysis of 164 patients275279, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68518]], camposKey:0902-0063 1997-02-01 Value of endothelin in cellular rejection after liver transplantation2528, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68519]], camposKey:0025-7753 1997-01-25 Hepatitis C virus recurrence after liver transplantation Recidiva de la hepatitis por el virus de la hepatitis C en los pacientes receptores de trasplante hepático98102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68520]], camposKey:0210-5705 1997-01-01 Chylous ascites in cirrhotic and non-cirrhotic patients Ascitis quilosa en pacientes cirróticos y no cirróticos.291294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68521]], camposKey:0025-7753 1996-02-24 Hepatitis B and C virus infection in patients with hepatocellular carcinoma Infección por los virus de la hepatitis B y C en pacientes con carcinoma hepatocelular241245, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68522]], camposKey:0025-7753 1994-01-01 Analysis of the DNA of the hepatitis B virus (HBV) in the serum and mononuclear cells of the peripheral blood in subjects with chronic infection by the HBV Análisis del ADN del virus de la hepatitis B (VHB) en suero y células mononucleares de sangre periférica en sujetos con infección crónica por el VHB.561566][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145639564]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f91e5][][][][][][][][][][][][][][][]

AYUDA A LA INVESTIGACIÓN

PUBLICACIONES

Artículos de revista (74)

Fuentes-Valenzuela E.; de Benito Sanz M.; Garcia-Pajares F.; Estradas J.; Peñas-Herrero I.; Dura-Gil M.; Carbajo A.Y.; de la Serna-Higuera C.; Sanchez-Ocana R.; Alonso-Martin C.; Almohalla C.; Sanchez-Antolin G.; Perez-Miranda M. Antimigration versus conventional fully covered metal stents in the endoscopic treatment of anastomotic biliary strictures after deceased-donor liver transplantation . SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 2023; 37(9): 6975-6982.

Enlace a la publicación
Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Convenios/Contratos OTC (1)

COLORECTAL CANCER OMICS COLLECTION. . Equipo Investigadores: SANCHEZ ANTOLIN, MARIA GLORIA (IP). Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: UNIVERSAL DIAGNOSTICS SL.. 16/11/2018

Ver Todos
 

OTROS

Tesis doctorales (1)

BUENO REQUENA, MARIA DEL PILAR RESPUESTA ACTIVA PROFIBRÓTICA EN SANGRE PERIFÉRICA EN PACIENTES CIRRÓTICOS.. Universidad de Valladolid; 2016

Texto completo en acceso abierto  
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados